Drugs that contain Sincalide
1. Kinevac patents expiration
KINEVAC Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6803046 | BRACCO | Sincalide formulations |
Aug, 2022
(1 year, 8 months ago) | |
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
KINEVAC family patents
2. Sincalide patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11318100 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(13 years from now) | |
| US11110063 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(13 years from now) | |
| US11737983 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(13 years from now) | |
Market Authorisation Date: 22 November, 2022
Treatment: Stimulate gallbladder contraction. as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis; Diagnostic imaging by ac...
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
SINCALIDE family patents